Document Detail


Hirudin therapy during thrombolysis for venous thrombosis in heparin-induced thrombocytopenia.
MedLine Citation:
PMID:  11213236     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Heparin-induced thrombocytopenia (HIT) is the most common drug-related thrombocytopenia. Thromboembolic complications occur in approximately 50% of patients with HIT and result in limb amputation and death in up to 20% and 30% respectively. Because patients with a history of HIT may require future intravenous anticoagulation but have a high-risk of thromboembolism if re-challenged with heparin, alternative therapies are necessary when further anticoagulation is indicated. The use of direct thrombin inhibitors in HIT patients who also require thrombolytic therapy offers unique challenges to anticoagulant monitoring and safety. We present a case of progressive ileofemoral deep venous thrombosis in a patient with a history of HIT in order to review the combined use of hirudin and thrombolysis in this setting.
Authors:
M P Reilly; R Weiss; A Askenase; C Tuite; M Soulen; E R Mohler
Related Documents :
1947076 - Venous thrombosis in patients who have undergone major hip or knee surgery: detection w...
2184996 - Pulmonary edema in severe falciparum malaria. hemodynamic study and clinicophysiologic ...
10726046 - Essential thrombocythemia in young adults: major thrombotic complications and complicat...
20671046 - Elevated d-dimers are also a marker of underlying malignancy and increased mortality in...
19859836 - Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathw...
3214596 - Isolation of swine-like influenza a(h1n1) viruses from man in switzerland and the nethe...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Vascular medicine (London, England)     Volume:  5     ISSN:  1358-863X     ISO Abbreviation:  Vasc Med     Publication Date:  2000  
Date Detail:
Created Date:  2001-02-12     Completed Date:  2001-06-07     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  9610930     Medline TA:  Vasc Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  239-42     Citation Subset:  IM    
Affiliation:
Department of Medicine, University of Pennsylvania, School of Medicine, Philadelphia, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anticoagulants / therapeutic use*
Heparin / adverse effects*
Hirudin Therapy*
Hirudins / analogs & derivatives*
Humans
Male
Middle Aged
Phlebography
Recombinant Proteins / therapeutic use*
Thrombocytopenia / chemically induced*,  radiography
Thrombolytic Therapy / methods*
Treatment Outcome
Venous Thrombosis / drug therapy*,  etiology,  radiography
Chemical
Reg. No./Substance:
0/Anticoagulants; 0/Hirudins; 0/Recombinant Proteins; 120993-53-5/desirudin; 9005-49-6/Heparin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Trial of a novel prostacyclin analog, UT-15, in patients with severe intermittent claudication.
Next Document:  Adenosine and chronic ischemia of the lower limbs.